Milestones

2006

Company incorporated and signed first deal.

2007
  • Opened Abex Technical Office in Pretoria.
  • Anita Smal joined as Regulatory Affairs Director in Sep 2007.
2008
  • First applications for registration submitted through our subsidiary, Lasara Traders.
  • Signed strategic consulting deal with Clicks Group to establish Unicorn.
2009
  • Formed Nucare in partnership with Carecross Health and developed first integrated e-scripting program in RSA.
  • Opened office in Shanghai, China.
  • Lasara Traders obtains its licence to manufacture and import medicines from the MCC.
2010
  • First MA registered (Nebivolol) and licensed out
  • Established as professional partner of EXTEDO to provide Software Solutions for eCTD and pharmacovigilance in South Africa.
  • Incorporated strategic JV in Australia and New Zealand and won first major tender bid overseas.
2011

Established JV trading partnership into certain South East Asian markets

2012
  • One of the first Quetiapine generics launched in South Africa.
  • Second to market with Sildenafil.
  • First major tender buyout awarded by DoH.
2014

First eCTD MA approved in South Africa by MCC for a generic medicine (Esomeprazole).

2015

Milestone of more than 100 approved SKUs.

2016
  • Signed Strategic Distribution Agreement with Clicks (Unicorn) Pharmacies.
  • First biosimilar Enoxaparin approved in EU and licensed out.
2017
  • Opened office in Cyprus and United Kingdom.
  • Established ABEX Consumer Division and signed exclusive rights to commercialize Nasaleze in SA.
2018
  • Established strategic JV in UK for pan EU sales footprint and RnD cooperation
  • First MA approved in UK (Gabapentin)
  • Acquired Eden Pharmaceuticals Pvt Ltd in Australia
2019
  • Launched five non-prescription Consumer Health brands into SA market.
  • Signed exclusive partnership with Enzymatica for the commercialization of ColdZyme in Australia and New Zealand.